7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity

Bioorg Med Chem. 2007 Jul 1;15(13):4543-51. doi: 10.1016/j.bmc.2007.04.013. Epub 2007 Apr 10.

Abstract

A series of 7-substituted melatonin and 1-methylmelatonin analogues were prepared and tested against human and amphibian melatonin receptors. 7-Substituents reduced the agonist potency of all the analogues in the Xenopus laevis melanophore assay, 7-bromomelatonin (5d) and N-butanoyl 7-bromo-5-methoxytryptamine (5f) being the most active compounds, but both were 42-fold less potent than melatonin (1). Whereas all the analogues bind with lower affinity at the human MT(1) receptor than melatonin, 5d, 5f and N-propanoyl 7-bromo-5-methoxytryptamine (5e) show a similar binding affinity to melatonin at the MT(2) receptor and consequently show some MT(2) selectivity. These results suggest that the receptor pocket around C-7 favours binding by an electronegative group, suggesting an electropositive region in this area of the receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemical synthesis
  • Antioxidants / metabolism
  • Antioxidants / pharmacology*
  • Cell Line
  • Humans
  • Melatonin / analogs & derivatives*
  • Melatonin / chemical synthesis
  • Melatonin / pharmacology*
  • Receptor, Melatonin, MT1 / drug effects
  • Receptor, Melatonin, MT1 / metabolism
  • Receptor, Melatonin, MT2 / drug effects
  • Receptor, Melatonin, MT2 / metabolism
  • Recombinant Proteins / metabolism
  • Structure-Activity Relationship
  • Xenopus laevis

Substances

  • Antioxidants
  • Receptor, Melatonin, MT1
  • Receptor, Melatonin, MT2
  • Recombinant Proteins
  • Melatonin